These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 15325606)

  • 1. Surgical stapler-associated fatalities and adverse events reported to the Food and Drug Administration.
    Brown SL; Woo EK
    J Am Coll Surg; 2004 Sep; 199(3):374-81. PubMed ID: 15325606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trocar-associated injuries and fatalities: an analysis of 1399 reports to the FDA.
    Fuller J; Ashar BS; Carey-Corrado J
    J Minim Invasive Gynecol; 2005; 12(4):302-7. PubMed ID: 16036187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silicone gel breast implant adverse event reports to the Food and Drug Administration, 1984-1995.
    Brown SL; Parmentier CM; Woo EK; Vishnuvajjala RL; Headrick ML
    Public Health Rep; 1998; 113(6):535-43. PubMed ID: 9847926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safe Medical Devices Act: management guidance for hospital compliance with the new FDA requirements.
    Alder HC
    Hosp Technol Ser; 1993 Oct; 12(11):1-27. PubMed ID: 10129209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, distributor reporting. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Jan; 65(17):4112-21. PubMed ID: 11010653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
    Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive endometrial ablation device complications and use outside of the manufacturers' instructions.
    Brown J; Blank K
    Obstet Gynecol; 2012 Oct; 120(4):865-70. PubMed ID: 22996104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients.
    Mahajan T; Dubin AM; Atkins DL; Bradley DJ; Shannon KM; Erickson CC; Franklin WH; Cecchin F; Berul CI;
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1270-4. PubMed ID: 18691353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM; Tanner LA; Milstien JB
    Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidural conduction device fractures and complications of retained fragments.
    Fischer R
    AANA J; 2008 Feb; 76(1):37-40. PubMed ID: 18323318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facilities strive to comply with new Act. The long-term effects of the Safe Medical Devices Act are still unknown.
    Schuster DK; Butler KH
    Health Prog; 1993 May; 74(4):53-7. PubMed ID: 10125364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of efficacy of heartworm preventive products at the FDA.
    Hampshire VA
    Vet Parasitol; 2005 Oct; 133(2-3):191-5. PubMed ID: 16099105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disproportionality analysis for signal detection of implantable cardioverter-defibrillator-related adverse events in the Food and Drug Administration Medical Device Reporting System.
    Duggirala HJ; Herz ND; Caños DA; Sullivan RA; Schaaf R; Pinnow E; Marinac-Dabic D
    Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):87-93. PubMed ID: 22095760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Introduction to the MAUDE database.
    Gurtcheff SE
    Clin Obstet Gynecol; 2008 Mar; 51(1):120-3. PubMed ID: 18303506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of FDA advisory on reported vacuum-assisted delivery and morbidity.
    Ross MG; Fresquez M; El-Haddad MA
    J Matern Fetal Med; 2000; 9(6):321-6. PubMed ID: 11243287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human bone morphogenetic protein-2: adverse events reported to the Manufacturer and User Facility Device Experience database.
    Woo EJ
    Spine J; 2012 Oct; 12(10):894-9. PubMed ID: 23098616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving patient care by reporting problems with medical devices.
    White GG; Weick-Brady MD; Goldman SA; Gross TP; Kennedy DL; Lucas BS; Merritt K; Naschinski C
    CRNA; 1998 Nov; 9(4):139-56. PubMed ID: 9866489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical device accident reporting: does it improve patient safety?
    Nobel JJ
    Stud Health Technol Inform; 1996; 28():29-35. PubMed ID: 10172828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.